Cargando…
“DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131023/ https://www.ncbi.nlm.nih.gov/pubmed/35646807 http://dx.doi.org/10.3389/fpubh.2022.835055 |
_version_ | 1784713098387521536 |
---|---|
author | Vatsyayan, Vindhya Pattery, Theresa Sayyad, Khasim Williams, Jason Pal, Arnab Panibatla, Vikas Khanna, Ashwani |
author_facet | Vatsyayan, Vindhya Pattery, Theresa Sayyad, Khasim Williams, Jason Pal, Arnab Panibatla, Vikas Khanna, Ashwani |
author_sort | Vatsyayan, Vindhya |
collection | PubMed |
description | BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A “DOST” intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services. METHODS: It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings. RESULTS: A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP. CONCLUSION: The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective. |
format | Online Article Text |
id | pubmed-9131023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91310232022-05-26 “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India Vatsyayan, Vindhya Pattery, Theresa Sayyad, Khasim Williams, Jason Pal, Arnab Panibatla, Vikas Khanna, Ashwani Front Public Health Public Health BACKGROUND: The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A “DOST” intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services. METHODS: It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings. RESULTS: A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP. CONCLUSION: The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective. Frontiers Media S.A. 2022-05-11 /pmc/articles/PMC9131023/ /pubmed/35646807 http://dx.doi.org/10.3389/fpubh.2022.835055 Text en Copyright © 2022 Vatsyayan, Pattery, Sayyad, Williams, Pal, Panibatla and Khanna. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Vatsyayan, Vindhya Pattery, Theresa Sayyad, Khasim Williams, Jason Pal, Arnab Panibatla, Vikas Khanna, Ashwani “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title | “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title_full | “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title_fullStr | “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title_full_unstemmed | “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title_short | “DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India |
title_sort | “dost” model to link and support drug resistant tb patients from private sector: an experience from delhi, india |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131023/ https://www.ncbi.nlm.nih.gov/pubmed/35646807 http://dx.doi.org/10.3389/fpubh.2022.835055 |
work_keys_str_mv | AT vatsyayanvindhya dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT patterytheresa dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT sayyadkhasim dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT williamsjason dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT palarnab dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT panibatlavikas dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia AT khannaashwani dostmodeltolinkandsupportdrugresistanttbpatientsfromprivatesectoranexperiencefromdelhiindia |